Track topics on Twitter Track topics that are important to you
PRA has written a new white paper on the considerations for planning and conducting global rare disease clinical trials. Rare disease trials are inherently designed to include fewer patients, are often longer in duration, and more frequently terminated than trials in more common indications. These challenges impact both sponsors and patients. A recent literature review […]
Original Article: Cross-Border Enrollment of Rare Disease PatientsNEXT ARTICLE
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...